doi: 10.1136/gutjnl-2024-331914 7 PaikJFierceYTreutingPMBrabbTMaggio-PriceL
"A young man escalated his dose of retatrutide, he experienced secretory diarrhoea, which was very severe, and he was admitted to hospital requiring a lot of intravenous fluid rehydration," Dr Holt said
Our programs incorporate the latest advancements in obesity treatment, including FDA-approved and off-label GLP-1, GIP, and combination therapies as part of a personalized, medically supervised approach
Finally, ongoing research is essential
Individual results vary based on the patients baseline metabolic rate, diet, and physical activity levels
What to monitor: The same factors as the 1 mg phase, plus blood glucose patterns if you monitor them, hydration status (GLP-1 agonists can reduce thirst cues), and mood or energy shifts that may indicate metabolic transition